Barnés DJA, Hernández CJG, González AN, Franco AO

Language: Spanish
References: 13
Page: 61-64
PDF size: 632.67 Kb.

ABSTRACT

Polypharmacy is considered when an individual uses four or more medications. We conducted a descriptiveretrospective study of elderly patients admitted to the National Institute of Angiology and Vascular Surgery (INACV) with peripheral vascular conditions during the months of July to September of 2016 treated with polypharmacy. The universe consisted of 90 patients. We reviewed the medical records and obtained the following variables: age, sex, associated comorbidities, diagnosis at admission, number of drugs prescribed and pharmacological groups most frequently used. The age group of 60-69 years old predominated, 41 patients (45.56%), mainly males. Prevalence of hypertension was observed in 64 cases (71.11%), followed by diabetes mellitus with 47 patients (52.22%) and ischemic heart disease with 25 cases (27.78%), associated comorbidities, the main diagnoses (21.35%), atherosclerosis obliterans (IVUS) grade IV, 16 cases (17.78%), and neuroinfectious diabetic foot, 14 cases (15.56%). As for polypharmacy, 16 patients received six drugs, the most frequently used pharmacological groups were represented by analgesics and anti-inflammatories in 81 patients (90.0%), antibiotics 73 patients (81.11%) and antihypertensives in 63 cases (70.0%). Emphasis is placed on the integral and multidisciplinary management of these patients to reduce polypharmacy and its consequences. To report the behavior of polypharmacy in elderly patients with peripheral vascular diseases.

REFERENCES

1. Oropesa D, González M, Calero LM. Reacciones medicamentosas adversas frecuentes en el anciano. Correo Científico Médico Holguín. [Internet]. 2004 [citado 9 de abril 2016]; 8(2). Disponible en: http://www.cocmed.sld.cu/no82/n82rev1.htm

2. Guerra MG. Polifarmacia y farmacología en geriatría [Internet]. México: UNAM; 2005 [citado 9 de abril 2016]. Disponible en: http:// www.facmed.unam.mx/deptos/salud/POLIFA%7E1.htm.

3. Martínez C, Pérez V, Carballo M, Larrondo J. Polifarmacia en los adultos mayores. Rev Cubana Med Gen Integr [Internet]. 2005 [citado 8 de abril 2016];21(1-2) Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252005000100012&ln g=es&nrm=iso&tlng=es#autor.

4. Aymat L de V, Díez del Corral ER. Polifarmacia en el paciente anciano. Jano.[Internet].2007[citado 8 de abril 2016];1.660 Disponible en: http://www.doyma.es/jano

5. Halling A, Fridh G, Ovhed I. Validating the Johns Hopkins ACG Case-Mix System of the elderly in Swedish primary health care. BMC Public Health; 2006. 6:171.Disponible en: http://www.biomedcentral.com/1471-2458/6/171.

6. Fernández N, Díaz D, Pérez B, Rojas A. Polifarmacia en el anciano. Acta Médica; 2002; 10 (1-2).

7. García LR, Carballo RR, Aquey MB, Hernández A, Corzo A. Caracterización de los adultos mayores con polifarmacia en la consulta de geriatría. Geroinfo 2010; 5 (1).

8. Guevara de León T, Nepomuceno NL, Hernández O. Polifarmacia en el adulto mayor. Medicentro 2010; 14 (2).

9. Serra M, Germán JL. Polifarmacia en el adulto mayor. Rev. Habanera de Ciencias Médicas. 2013; 12 (3).

10. Richard BD, Björn D, Sverre EK, Stevo PA, Areth B, et al. Effects of Losartan or Atenolol in Hypertensive patients without Clinically Evident Vascular Disease: Substudy of the LIFE Randomized Trial. Ann Intern MED. 2006 Aug; (139): 169-177.

11. González RL. Caídas en el anciano. Consideraciones generales y prevención. Rev. Cubana MGI. 2011;15 (1):98-100.

12. Badillo U. La prescripción en el anciano: cuidado con la polifarmacia y los efectos adversos. Rev Hosp Jua Mex. 2005; 72 (1):18-22.

13. Ramos AM, Milián PM, Fonseca JL, Quirós M. Determinación de polifarmacoterapia en pacientes geriátricos de un consultorio del médico de la familia en Cienfuegos. Rev Cubana Farm. 2000; 34 (3).